(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ADMA BIOLOGICS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

ADMA BIOLOGICS

ST13

US500000098538534

Class

5

Filing

98538534

Registration

7766088

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

17

Latest update

04/23/2025

Trademark type

Combined

Nice classes

5

Filing date

05/07/2024

Registration date

04/22/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/22/2025

Last transaction

04/23/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

09/26/2019

First use in commerce

09/26/2019

Drawing code

3

Owner type

16

Owner location

Boca Raton, FL

Examiner

REED, MAUREEN

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of white text over a blue background with the word "ADMA" above the word "BIOLOGICS" to the left of a white droplet shape with yellow shading.

Holders and representatives

Holders

ADMA BioManufacturing, LLC

Representatives

David W. Staple Casimir Jones, S.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparationsIVIG (Intravenous Immunoglobulin); immune globulin and hyperimmune globulin for pharmaceutical purposes; immune globulin and hyperimmune globulin preparations for the treatment of primary and secondary immunodeficiencies; immune globulin and hyperimmune globulin preparations for the prevention or treatment of infectious diseases; hyperimmune globulin preparation for the prevention or treatment of hepatitis B

Publications

History of USPTO decisions and trademark events.

17 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/22/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

04/22/2025

PUBO

PUBLISHED FOR OPPOSITION

03/04/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/04/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/26/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/11/2025

XAEC

EXAMINER'S AMENDMENT ENTERED

02/11/2025

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

02/11/2025

GNEA

EXAMINERS AMENDMENT E-MAILED

02/11/2025

CNEA

EXAMINERS AMENDMENT -WRITTEN

02/11/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/26/2024

GNRT

NON-FINAL ACTION E-MAILED

11/26/2024

CNRT

NON-FINAL ACTION WRITTEN

11/26/2024

DOCK

ASSIGNED TO EXAMINER

11/21/2024

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

11/05/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/05/2024

NWAP

NEW APPLICATION ENTERED

05/07/2024

Continuous trademark protection

Get notified about every new filing that threatens ADMA BIOLOGICS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.